Skip to main content
Skip to main content
MHUAF logo

Meihua International Medical Technologies Co., Ltd. (MHUAF)

$9.00 $-0.10 (-1.10%) |CouncilHOLD · 43 · C
Bottom line: HOLD — our Council read (43/100) and AI Score (43/100) broadly agree.
MCap: $6.28M| Vol: 257|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Meihua International Medical Technologies Co., Ltd. (MHUAF) trades at $9.00 with AI Score 43/100 (Grade C). Meihua International Medical Technologies Co. , Ltd. Market cap: $6.28M, Sector: Healthcare.

Price live · AI analysis from Mar 17, 2026
Meihua International Medical Technologies Co., Ltd. is a China-based manufacturer of disposable medical devices, serving hospitals, pharmacies, and medical institutions globally. The company offers a range of Class I, II, and III medical devices, including X-ray films, anesthesia kits, and infusion pumps.

Analyst Coverage for MHUAF: MHUAF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MHUAF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 43/100 · C

MHUAF: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Meihua International Medical Technologies Co., Ltd. (MHUAF) Healthcare & Pipeline Overview

CEOLee Leyi
Employees619
HeadquartersYangzhou, CN
IPO Year2022

Meihua International Medical Technologies Co., Ltd., based in China, develops, manufactures, and sells a diverse portfolio of disposable medical devices, including Class I, II, and III products, serving a global market and competing within the medical instruments and supplies industry.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 17, 2026

What Is the Investment Thesis for MHUAF?

Meihua International Medical Technologies Co., Ltd. presents a compelling investment case based on its established presence in the disposable medical device market and its global distribution network. With a P/E ratio of 0.30 and a profit margin of 10.4%, the company demonstrates profitability. Key value drivers include the increasing demand for disposable medical devices, especially in emerging markets, and the company's ability to offer a diverse product range. Growth catalysts involve expanding its product offerings and penetrating new geographic markets. Potential risks include regulatory changes in the medical device industry and competition from established players. The company's beta of 1.02 indicates market correlation.

Based on FMP financials and quantitative analysis

MHUAF Key Highlights

  • Market capitalization of $6.28M indicates a small-cap company with growth potential.
  • P/E ratio of 0.30 suggests the company may be undervalued compared to its earnings.
  • Profit margin of 10.4% demonstrates the company's ability to generate profit from its revenue.
  • Gross margin of 34.2% reflects the efficiency of the company's production and pricing strategies.
  • The company exports its products to multiple continents, indicating a global presence.

Who Are MHUAF's Competitors?

MHUAF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
BFRI Biofrontera Inc. $1.15 +13.58% $14.69M
LUCY Innovative Eyewear, Inc. $1.29 +70.39% $5.17M
NYXH Nyxoah S.A. $1.75 +1.74% $69.31M 69
KMTS Kestra Medical Technologies, Ltd. $27.70 +2.67% $1.62B 67
ZTEK Zentek Ltd. $0.46 +2.88% $49.90M 63
OMIC Singular Genomics Systems, Inc. $20.01 +0.00% $50.77M 61
BLMHF Bloom Health Partners Inc. $0.11 +0.00% $5.22M 51
FSPKF Fisher & Paykel Healthcare Corporation Limited $22.52 +0.00% $13.23B 51

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are MHUAF's Key Strengths?

  • Diverse product portfolio covering multiple classes of medical devices.
  • Established manufacturing base in China.
  • Global export reach to various continents.
  • Long-standing experience in the medical device industry.

What Are MHUAF's Weaknesses?

  • Small market capitalization may limit access to capital.
  • Reliance on disposable medical devices may be affected by environmental concerns.
  • Limited brand recognition compared to larger competitors.
  • OTC market listing may pose liquidity challenges.

What Could Drive MHUAF Stock Higher?

  • Expansion into new geographic markets, particularly in emerging economies.
  • Development and launch of new medical devices to expand product offerings.
  • Strategic partnerships and acquisitions to enhance market reach and technology capabilities.

What Are the Key Risks for MHUAF?

  • Regulatory changes in the medical device industry affecting product approvals and compliance.
  • Increased competition from established medical device companies.
  • Fluctuations in currency exchange rates impacting export revenues.
  • Limited liquidity due to OTC market listing.
  • Dependence on disposable medical devices may be affected by environmental concerns.

What Are the Growth Opportunities for MHUAF?

  • Expansion into Emerging Markets: Meihua International can capitalize on the growing healthcare infrastructure in emerging markets, particularly in Asia and Africa. These regions are experiencing increased demand for affordable disposable medical devices due to expanding healthcare access and rising awareness of hygiene standards. By establishing strategic partnerships and distribution networks in these markets, Meihua International can significantly increase its revenue streams. The emerging markets medical device market is expected to grow at a CAGR of 8-10% over the next five years.
  • Product Innovation and Diversification: Investing in research and development to expand its product portfolio with innovative and specialized medical devices can drive growth. Focusing on high-demand areas such as minimally invasive surgical instruments and advanced wound care products can attract new customers and increase market share. The company can also explore developing products tailored to specific regional healthcare needs. The global market for advanced wound care products is projected to reach $22 billion by 2028.
  • Strategic Alliances and Acquisitions: Forming strategic alliances with established medical device companies or acquiring smaller, innovative firms can provide access to new technologies, markets, and distribution channels. Collaborations can also facilitate the development of co-branded products and the sharing of resources, reducing costs and enhancing competitiveness. The medical device industry is witnessing increasing consolidation, with strategic acquisitions playing a key role in growth.
  • Enhancing Online Presence and E-commerce Capabilities: Establishing a robust online presence and developing e-commerce capabilities can enable Meihua International to reach a wider customer base and streamline its sales processes. An online platform can facilitate direct sales to hospitals, pharmacies, and medical institutions, reducing reliance on intermediaries and improving profit margins. The global e-commerce market for medical devices is experiencing rapid growth, driven by increasing internet penetration and the convenience of online purchasing.
  • Focus on Sustainable and Eco-Friendly Products: Developing and marketing sustainable and eco-friendly medical devices can appeal to environmentally conscious customers and enhance the company's brand image. Using biodegradable materials and implementing environmentally responsible manufacturing processes can differentiate Meihua International from its competitors and attract a growing segment of the market. The demand for sustainable medical devices is increasing, driven by growing environmental awareness and regulatory pressures.

What Opportunities Does MHUAF Have?

  • Expansion into emerging markets with growing healthcare needs.
  • Development of innovative and specialized medical devices.
  • Strategic alliances and acquisitions to expand market reach.
  • Enhancing online presence and e-commerce capabilities.

What Threats Does MHUAF Face?

  • Intense competition from established medical device companies.
  • Regulatory changes and compliance requirements in different markets.
  • Fluctuations in currency exchange rates affecting export revenues.
  • Potential disruptions in the supply chain due to global events.

What Are MHUAF's Competitive Advantages?

  • Established manufacturing capabilities in China.
  • Diverse product portfolio of Class I, II, and III medical devices.
  • Global distribution network with exports to multiple continents.
  • Long-standing relationships with hospitals and medical institutions.

What Does MHUAF Do?

Founded in 1991 and headquartered in Yangzhou, China, Meihua International Medical Technologies Co., Ltd. specializes in the research, development, manufacture, and sale of a wide array of disposable medical devices. The company's product portfolio is categorized into Class I, Class II, and Class III medical devices. Class I products include disposable medical X-ray films, medical dry films, gauze bandages, examination gloves, and pharmaceutical packaging materials. Class II products consist of disposable full anesthesia kits, medical brushes, women's examination kits, and various catheters and masks. Class III products include disposable infusion pumps and anesthesia puncture kits. Meihua International serves a diverse clientele, including hospitals, pharmacies, medical institutions, and medical equipment companies. The company has expanded its market reach beyond China, exporting its products to Europe, North America, South America, Asia, Africa, and Oceania. This global presence underscores the company's commitment to meeting international healthcare demands. Meihua International Medical Technologies Co., Ltd. continues to focus on innovation and quality in the medical device sector.

What Products and Services Does MHUAF Offer?

  • Researches and develops disposable medical devices.
  • Manufactures Class I, II, and III medical devices.
  • Sells medical devices to hospitals, pharmacies, and medical institutions.
  • Exports products to Europe, North America, South America, Asia, Africa, and Oceania.
  • Offers disposable medical X-ray films and dry films.
  • Produces anesthesia kits and infusion pumps.
  • Provides medical polymer materials and products.

How Does MHUAF Make Money?

  • Manufacturing and selling disposable medical devices.
  • Generating revenue through direct sales to hospitals and medical institutions.
  • Exporting products to international markets.
  • Developing and commercializing new medical device technologies.

What Industry Does MHUAF Operate In?

Meihua International Medical Technologies Co., Ltd. operates within the medical instruments and supplies industry, a sector characterized by continuous innovation and increasing demand due to an aging global population and rising healthcare expenditures. The market is competitive, with numerous players offering similar products. The company's focus on disposable medical devices aligns with the industry's trend towards infection control and convenience. The global medical devices market is projected to reach $600 billion by 2025, presenting significant growth opportunities for companies like Meihua International.

Who Are MHUAF's Key Customers?

  • Hospitals
  • Pharmacies
  • Medical institutions
  • Medical equipment companies
AI Confidence: 71% Updated: Mar 17, 2026

ROE 4%Key Financial Metrics

Return on equity for Meihua International Medical Technologies Co., Ltd. stands at 3.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.3%, showing how much profit it generates from its asset base. MHUAF trades at a trailing price-to-earnings ratio of 0.92, below the Healthcare sector average of ~23x. Its free cash flow yield is 8.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 8.42 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 108.3%, the inverse of the P/E and a quick read on earnings relative to price.

How Meihua International Medical Technologies Co., Ltd. Is Valued

Meihua International Medical Technologies Co., Ltd. carries a market capitalization of $6.28M, placing it in the micro-cap category. Relative to its peer group, MHUAF's quantitative score of 43/100 is below the peer average of 66/100.

F-Score 4/9Financial Health

Meihua International Medical Technologies Co., Ltd.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.88 places it in the grey zone, a middle ground that warrants monitoring.

MHUAF Financials

Fundamental Snapshot

Revenue Growth (FY)
-36.2%
Net Income Growth (FY)
-37.5%
EPS Growth (FY)
-54.9%
Free Cash Flow Growth (FY)
-96.2%
P/E (TTM)
0.9
Return on Equity (TTM)
+3.8%
Current Ratio
8.4

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Diverse product portfolio covering multiple classes of medical devices.
  • Established manufacturing base in China.
  • Global export reach to various continents.
  • Long-standing experience in the medical device industry.

Bear Case

  • Small market capitalization may limit access to capital.
  • Reliance on disposable medical devices may be affected by environmental concerns.
  • Limited brand recognition compared to larger competitors.
  • OTC market listing may pose liquidity challenges.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

MHUAF Latest News

No recent news available for MHUAF.

MHUAF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MHUAF.

Price Targets

Wall Street price target analysis for MHUAF.

MHUAF MoonshotScore

43/100

What does this score mean?

The MoonshotScore rates MHUAF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Lee Leyi

Unknown

Information on Lee Leyi's background is not available in the provided data. Without further information, a detailed career history, education, and previous roles cannot be accurately provided. Lee Leyi currently manages 619 employees at Meihua International Medical Technologies Co., Ltd.

Track Record: Information on Lee Leyi's track record is not available in the provided data. Key achievements, strategic decisions, and company milestones under their leadership cannot be accurately assessed without additional information.

MHUAF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Meihua International Medical Technologies Co., Ltd. may not meet the minimum financial standards required for higher tiers like OTCQB or OTCQX. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and requires increased due diligence from investors.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: As an OTC Other stock, MHUAF likely experiences lower trading volumes and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more difficult for investors to buy or sell shares quickly and at desired prices. The limited liquidity may also increase price volatility, making it important for investors to exercise caution and use limit orders.
OTC Risk Factors:
  • Limited financial disclosure and regulatory oversight.
  • Lower trading volumes and liquidity.
  • Higher price volatility.
  • Potential for fraud or manipulation.
  • Increased risk of delisting or going dark.
Due Diligence Checklist:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Review the company's OTC Markets profile for any disclosures or warnings.
  • Consult with a financial advisor before investing.
  • Understand the risks associated with OTC investments.
  • Check for any news or press releases about the company.
Legitimacy Signals:
  • The company has been in operation since 1991.
  • The company has a global export reach.
  • The company has a diverse product portfolio.
  • The company has a P/E ratio of 0.30 and a profit margin of 10.4%.

Meihua International Medical Technologies Co., Ltd. Healthcare Stock: Key Questions Answered

What does Meihua International Medical Technologies Co., Ltd. do?

Meihua International Medical Technologies Co., Ltd. is a China-based company that specializes in the research, development, manufacture, and sale of disposable medical devices. The company offers a diverse range of products, including Class I, II, and III medical devices, such as X-ray films, anesthesia kits, infusion pumps, and various other medical supplies. Meihua International serves hospitals, pharmacies, medical institutions, and medical equipment companies globally, with a significant export presence in Europe, North America, South America, Asia, Africa, and Oceania. The company focuses on providing affordable and reliable medical devices to meet the growing healthcare demands worldwide.

What are the main risks for MHUAF?

Meihua International Medical Technologies Co., Ltd. faces several risks, including regulatory changes in the medical device industry, which could affect product approvals and compliance. Increased competition from larger, more established medical device companies poses a threat to market share. Fluctuations in currency exchange rates could impact export revenues. As an OTC-listed company, MHUAF faces liquidity risks and potential price volatility. Additionally, the company's reliance on disposable medical devices may be affected by growing environmental concerns and the shift towards more sustainable healthcare practices. Investors should carefully assess these risks before investing.

What are the key factors to evaluate for MHUAF?

Meihua International Medical Technologies Co., Ltd. (MHUAF) holds an AI score of 43/100 (low). Not financial advice.

How frequently does MHUAF data refresh on this page?

MHUAF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven MHUAF's recent stock price performance?

Meihua International Medical Technologies Co., Ltd. (MHUAF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio covering multiple classes of medical devices. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider MHUAF overvalued or undervalued right now?

Valuing Meihua International Medical Technologies Co., Ltd. (MHUAF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying MHUAF?

Before investing in Meihua International Medical Technologies Co., Ltd. (MHUAF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding MHUAF to a portfolio?

Key strength of Meihua International Medical Technologies Co., Ltd. (MHUAF): Diverse product portfolio covering multiple classes of medical devices. Weigh rewards against risks and diversify. Not financial advice.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data as of 2026-03-17.
  • OTC market data may be limited and less reliable than major exchange data.
  • AI analysis is pending and may provide further insights.
Data Sources

Popular Stocks